Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.5.0.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Operating Activities:    
Net loss $ (14,286) $ (15,077)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on warrants [note 4 and note 5 [f]] (755) (166)
Depreciation 148 178
Stock-based compensation [note 5 [c] and note 5 [d]] 1,253 1,940
Recovery of lease termination loss [note 7] (1,250)  
Changes in operating assets and liabilities:    
Interest receivable 75 65
Amounts receivable (144) 5,663
Prepaid expenses and other assets 364 1,554
Accounts payable (300) 1,707
Accrued liabilities other (39) (2,052)
Accrued clinical liabilities (2,852) (3,494)
Accrued compensation 155 277
Restricted cash   29
Excess lease liability   (194)
Lease obligation (33) 113
Deferred collaboration revenue [note 3] (5,040) 11,041
Net cash (used in) provided by operating activities (22,704) 1,584
Financing Activities:    
Proceeds from purchase agreement with Lincoln Park Capital, net of issuance costs   17,629
Taxes paid related to net share settlement of equity awards   (52)
Net cash (used in) provided by financing activities   17,577
Investing Activities:    
Purchase of investments (34,125) (22,942)
Proceeds from sale of investments   1,003
Proceeds from maturities of investments 34,358 17,659
Purchase of property and equipment (39) (301)
Net cash (used in) provided by investing activities 194 (4,581)
Net (decrease) increase in cash and cash equivalents (22,510) 14,580
Cash and cash equivalents at beginning of period 34,310 27,897
Cash and cash equivalents at end of period $ 11,800 42,477
Non cash financing activities    
Issued common stock in consideration for the purchase agreement with Lincoln Park Capital   $ 254